The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study
Background. According to recent guidelines, all hospitalized patients with COVID-19 should receive pharmacological prophylaxis for venous thromboembolism (VTE), unless there are specific contraindications. However, the optimal preventive strategy in terms of intensity of anticoagulation for these pa...
Main Authors: | Pierpaolo Di Micco, Antonella Tufano, Giuseppe Cardillo, Egidio Imbalzano, Maria Amitrano, Corrado Lodigiani, Annamaria Bellizzi, Giuseppe Camporese, Antonella Cavalli, Carmela De Stefano, Vincenzo Russo, Antonio Voza, Alessandro Perrella, Paolo Prandoni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/9/1720 |
Similar Items
-
Is the use of warfarin becoming obsolete?
by: Tarek Haykal, et al.
Published: (2021-05-01) -
Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA
by: Alpesh Amin, et al.
Published: (2019-01-01) -
Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question
by: Giuseppe Camporese, et al.
Published: (2023-05-01) -
Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question
by: Giuseppe Camporese, et al.
Published: (2023-05-01) -
Heparin and SARS-CoV-2: Multiple Pathophysiological Links
by: Pierpaolo Di Micco, et al.
Published: (2021-12-01)